ROSA, ROBERTA
 Distribuzione geografica
Continente #
EU - Europa 462
NA - Nord America 338
AS - Asia 172
AF - Africa 20
SA - Sud America 16
Totale 1.008
Nazione #
US - Stati Uniti d'America 320
RU - Federazione Russa 205
IT - Italia 138
SG - Singapore 73
CN - Cina 46
HK - Hong Kong 33
FI - Finlandia 26
DE - Germania 21
IE - Irlanda 19
CA - Canada 18
BR - Brasile 15
CI - Costa d'Avorio 15
FR - Francia 14
NL - Olanda 14
GB - Regno Unito 8
BE - Belgio 6
VN - Vietnam 6
PL - Polonia 5
IN - India 3
ZA - Sudafrica 3
ES - Italia 2
JP - Giappone 2
LT - Lituania 2
PK - Pakistan 2
SA - Arabia Saudita 2
SI - Slovenia 2
AR - Argentina 1
BD - Bangladesh 1
ET - Etiopia 1
IR - Iran 1
KG - Kirghizistan 1
MA - Marocco 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 1.008
Città #
Chandler 66
Moscow 53
Singapore 45
Napoli 42
Hong Kong 33
Santa Clara 22
Naples 20
Ashburn 16
Ottawa 16
Amsterdam 14
Nanjing 14
Princeton 14
Beijing 13
Millbury 13
Turku 9
Des Moines 7
Helsinki 7
Munich 7
Boston 6
Brussels 6
Hicksville 6
Villarosa 6
Wilmington 6
Caserta 5
Dong Ket 4
London 4
Falkenstein 3
Frankfurt am Main 3
Palma Campania 3
San Mateo 3
Seattle 3
Turin 3
Warsaw 3
Belo Horizonte 2
Bexley 2
Boardman 2
Changsha 2
Hebei 2
Ho Chi Minh City 2
Jiaxing 2
Los Angeles 2
Nanchang 2
Osimo 2
Pune 2
Redwood City 2
Rome 2
Shenyang 2
Tianjin 2
Toronto 2
Trieste 2
Wroclaw 2
Addis Ababa 1
Alvignanello 1
Ardabil 1
Avellino 1
Benevides 1
Betim 1
Bishkek 1
Bom Jesus da Lapa 1
Botucatu 1
Brooklyn 1
Campinas 1
Casablanca 1
Casoria 1
Cañuelas 1
Changchun 1
Charlotte 1
Charqueada 1
Crateús 1
Curitiba 1
Dallas 1
Dammam 1
Dhaka 1
Dublin 1
Indaiatuba 1
Indiana 1
Islamabad 1
Istanbul 1
Jacksonville 1
Jeddah 1
Kochi 1
Lagoa Santa 1
Lawrence 1
Leawood 1
Louisville 1
Madison 1
Manchester 1
Marigliano 1
Monmouth Junction 1
Montalbano Jonico 1
Mountain View 1
New York 1
Norwalk 1
Nova Era 1
Nova Lima 1
Nuremberg 1
Osaka 1
Palermo 1
Pizzo 1
Porto Alegre 1
Totale 560
Nome #
Urokinase-type plasminogen activator receptor (uPAR) expression enhances invasion and metastasis in RAS mutated tumors 126
Development of 1,2,3-Triazole-Based Sphingosine Kinase Inhibitors and Their Evaluation as Antiproliferative Agents 108
Toll-like receptor 9 agonist IMO cooperates with everolimus in renal cell carcinoma by interfering with tumour growth and angiogenesis. 78
Everolimus induces Met inactivation by disrupting the FKBP12/Met complex 77
Mechanisms of resistance to mTOR inhibitors 77
Angiogenic and signalling proteins correlate with sensitivity to sequential treatment in renal cell cancer 76
Mechanisms of lapatinib resistance in HER2-driven breast cancer 71
Approaches for targeting cancer stem cells drug resistance 68
A Novel Toll-Like Receptor 9 Agonist Cooperates with Trastuzumab in Trastuzumab-Resistant Breast Tumors through Multiple Mechanisms of Action 64
Toll-like receptor 9 agonist IMO cooperates with cetuximab in K-ras mutant colorectal and pancreatic cancers. 56
Sphingosine Kinase 1 (SphK1) overespression contributes to cetuximab resistance in human colrectal cancer. 55
Integr(at)in(g) EGFR therapy in HNSCC 50
In Vitro and in Vivo Models for Analysis of Resistance to Anticancer Molecular Therapies. 48
High mobility group A1 protein expression reduces the sensitivity of colon and thyroid cancer cells to antineoplastic drugs. 43
EGFR-targeting agents in oncology 42
Totale 1.039
Categoria #
all - tutte 3.885
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.885


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010 0 0 0 0 0 0 0 0 0 0 0 10
2020/202138 1 0 2 0 4 8 2 5 6 0 6 4
2021/2022105 0 0 3 13 1 1 1 6 18 9 25 28
2022/2023152 15 12 8 8 23 23 1 14 24 15 4 5
2023/202489 3 12 13 7 4 11 0 15 0 2 16 6
2024/2025467 16 21 2 4 18 38 45 35 19 47 212 10
Totale 1.039